INTELLIGENT BIO SOLUTIONS INC. Treasury Stock, Value
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Treasury Stock, Value of $1 as of 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2026-08-19
- 2026-06-30: Treasury Stock, Value $1.00.
- 2026-03-31: Treasury Stock, Value $1.00.
- 2025-12-31: Treasury Stock, Value $1.00.
- 2025-09-30: Treasury Stock, Value $1.00.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2026-06-30 | $1.00 10-K · filed 2026-08-19 | |
| 2026-03-31 | $1.00 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $1.00 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $1.00 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.00 10-K · filed 2026-08-19 | |
| 2025-03-31 | $1.00 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.00 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $1.00 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.00 10-K · filed 2025-08-15 | |
| 2024-03-31 | $1.00 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.00 10-Q · filed 2024-02-09 | |
| 2023-09-30 | $14.00 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $1.00 10-K · filed 2024-09-18 | $14.00 10-K · filed 2023-08-23 |
| 2023-03-31 | $14.00 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $14.00 10-Q · filed 2023-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |